LONG ANDREW G (Chief Financial Officer) received a stock award from INSYS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/7/2018ACC: 0001209191-18-045652
Officer· Chief Financial Officer
Since Aug 2018
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
5K acquired · 5K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
—
Trade value
—
% of position
New position
8/7/2018
0.00→5K
Total
Net shares
+5K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/7/2018 | A · Award | +5K | — | — | New position | 0.00 | 5K |
| Total | +5K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
Held after
10K
Exercisable
—
8/7/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock5K shares | 8/7/2018 | D · Disposition | −5K | — | 10K |